Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solid Biosciences Inc. Director's Dealing 2018

Jan 26, 2018

33003_dirs_2018-01-25_40c71500-5a34-41b3-ab63-7c184350f07b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Solid Biosciences, LLC (SLDB)
CIK: 0001707502
Period of Report: 2018-01-25

Reporting Person: Shah Rajeev M. (Director)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1689444 Indirect

Footnotes

F1: Represents 1,368,981 shares of Common Stock held by RA Capital Healthcare Fund, L.P. (the "Fund") and 320,463 shares of Common Stock held in an account owned by a separately managed account (the "Account").

F2: RA Capital Management, LLC (the "Adviser") is the general partner of the Fund and the investment adviser of the Account. Peter Kolchinsky is the sole manager of the Adviser, and Mr. Shah is a member of the Adviser. Mr. Shah has no pecuniary interest in the reported securities held in the Account and therefore disclaims beneficial ownership of those securities. Mr. Shah disclaims beneficial ownership of the reported securities held by the Fund except to the extent of his pecuniary interest therein.